Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Tejnaksh Healthcare Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Tejnaksh Healthcare Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Tejnaksh Healthcare - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    24 Feb 2025, 12:22PM Please find the Scrutinizer Report for the meeting held on 22nd Feb 2025 commenced at 3.00 pm concluded at 3.10 pm
  • Tejnaksh Healthcare - Shareholder Meeting / Postal Ballot-Outcome of EGM

    22 Feb 2025, 5:11PM Please find the summary of the proceeding of the meeting held on 22nd Feb 2025 commenced at 3.00 pm concluded at 3.10 pm
  • Tejnaksh Healthcare - Integrated Filing (Financial)

    12 Feb 2025, 3:09PM Please find Result of Integrated filing as of Dec 2024
  • Tejnaksh Healthcare Q3 net profit up 30.91% at Rs 0.72 cr

    12 Feb 2025, 10:00AM The company reported standalone net profit of Rs 0.72 crore for the quarter ended December 31, 2024 as compared to Rs 0.55 crore in the same period la
  • Tejnaksh Healthcare - Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 31St De

    11 Feb 2025, 11:12PM Please find attached financial result as on 31st Dec 24 along with Limited review audit report
  • Tejnaksh Healthcare - Board Meeting Outcome for Outcome Of The Board Meeting Held On 11Th February 2025 Under Regulation 30 O

    11 Feb 2025, 11:08PM We hereby inform you that the Board of Directors of the Company in its meeting held today\r\non February 11, 2025, have, inter alia, considered and ap
  • Tejnaksh Healthcare - Extra Ordinary General Meeting ('EOGM') Of The Members Of Tejnaksh Healthcare Limited Is Scheduled To

    30 Jan 2025, 12:15PM Notice is hereby given to discuss the business transaction mentioned in the notice attached.\r\n\r\nPlease refer the notice for more information.
  • Tejnaksh Healthcare - Extra Ordinary General Meeting ('EOGM') Of The Members Of Tejnaksh Healthcare Limited Is Scheduled To

    30 Jan 2025, 12:15PM Notice is hereby given to discuss the business transaction mentioned in the notice attached.\r\n\r\nPlease refer the notice for more information.
  • Tejnaksh Healthcare - Extra Ordinary General Meeting ('EOGM') Of The Members Of Tejnaksh Healthcare Limited Is Scheduled To

    30 Jan 2025, 12:15PM Notice is hereby given to discuss the business transaction mentioned in the notice attached.\r\n\r\nPlease refer the notice for more information.
  • Tejnaksh Healthcare - Extra Ordinary General Meeting ('EOGM') Of The Members Of Tejnaksh Healthcare Limited Is Scheduled To

    30 Jan 2025, 12:15PM Notice is hereby given to discuss the business transaction mentioned in the notice attached.\r\n\r\nPlease refer the notice for more information.
  • Tejnaksh Healthcare - Extra Ordinary General Meeting ('EOGM') Of The Members Of Tejnaksh Healthcare Limited Is Scheduled To

    30 Jan 2025, 12:15PM Notice is hereby given to discuss the business transaction mentioned in the notice attached.\r\n\r\nPlease refer the notice for more information.
  • Tejnaksh Healthcare - Extra Ordinary General Meeting ('EOGM') Of The Members Of Tejnaksh Healthcare Limited Is Scheduled To

    30 Jan 2025, 12:15PM Notice is hereby given to discuss the business transaction mentioned in the notice attached.\r\n\r\nPlease refer the notice for more information.
  • Tejnaksh Healthcare - Extra Ordinary General Meeting ('EOGM') Of The Members Of Tejnaksh Healthcare Limited Is Scheduled To

    30 Jan 2025, 12:15PM Notice is hereby given to discuss the business transaction mentioned in the notice attached.\r\n\r\nPlease refer the notice for more information.
  • Tejnaksh Healthcare - Extra Ordinary General Meeting ('EOGM') Of The Members Of Tejnaksh Healthcare Limited Is Scheduled To

    30 Jan 2025, 12:15PM Notice is hereby given to discuss the business transaction mentioned in the notice attached.\r\n\r\nPlease refer the notice for more information.
  • Tejnaksh Healthcare - Extra Ordinary General Meeting ('EOGM') Of The Members Of Tejnaksh Healthcare Limited Is Scheduled To

    30 Jan 2025, 12:15PM Notice is hereby given to discuss the business transaction mentioned in the notice attached.\r\n\r\nPlease refer the notice for more information.
  • Tejnaksh Healthcare - Announcement under Regulation 30 (LODR)-Raising of Funds

    24 Jan 2025, 1:32AM Revision of Outcome of the board meeting held on 23rd January 2025. \r\n\r\nDue to Inadvertence/Typographical error proposed right issue approved by t
  • Tejnaksh Healthcare - Board Meeting Outcome for Outcome Of The Board Meeting Held On 23Rd January, 2025 Under Regulation 30 O

    23 Jan 2025, 6:05PM Please refer board outcome in the letter attached
  • Tejnaksh Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    20 Jan 2025, 8:30AM As of December 2024, 73.83% is owned by Indian Promoters and 26.17% by Public. <p align=justify> Top three Promoters holding highest number of shares
  • Tejnaksh Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    19 Jan 2025, 9:05PM Please refer compliance certificate attached.
  • Tejnaksh Healthcare - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations

    17 Jan 2025, 12:43AM Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 ,inter alia, to consider

Key fundamentals

Evaluate the intrinsic value of Tejnaksh Healthcare Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 26.886 26.8776 25.8822 21.249 21.6685
Liabilities 26.886 26.8776 25.8822 21.249 21.6685
Equity 10.1568 10.1568 10.1568 10.1568 10.1568
Gross Profit 3.6393 3.1304 4.3031 3.5848 3.1979
Net Profit 1.8125 1.3799 2.5188 2.0041 1.9235
Cash From Operating Activities 4.1461 1.9032 9.1263 0.8364 1.0017
NPM(%) 22.04 18.81 31.02 23.41 17.27
Revenue 8.2215 7.3351 8.1178 8.558 11.1376
Expenses 4.5822 4.2047 3.8147 4.9732 7.9397
ROE(%) 7.31 5.56 10.16 8.08 7.76

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Tejnaksh Healthcare Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 809.25 -0.64 11.41 13.03 1321.50 1.42
Lotus Eye Hospital and Institute Ltd 58.19 1.50 237.75 47.48 14.01 0.88
Bharat Immunological and Biologicals Corporation Ltd 21.32 -1.30 0.00 98.58 -39.50 0.00
Astec Lifesciences Ltd 654.90 -5.39 0.00 44.77 -239.30 0.00

Company Info

The Company incorporated in Mumbai as "Tejnaksh Healthcare Private Limited" as on 18th February, 2008 as a private limited company under provision of companies Act 1956. Company was converted in to a Public Limited Company and consequently the name was changed to "Tejnaksh Healthcare Limited" vide fresh certificate of incorporation dated 10th March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra.We run an Institute of Urology, an ISO certified the international level Urology hospital, located in the heart of Dhule city, Maharashtra, India. The 24000 Sq. Ft. campus has a four storey building which houses the complete Urology setup. It provides a comprehensive range of services from consultations and investigations to treatment for Urology.We are equipped with all latest equipment and provide the whole range of services, the patients from local area do not feel the need to go to metropolitan areas for urological problems. The Institute is recognized by National board of examinations for DNB (Urology). The Institute boasts of 150 research publications and 23 innovations.We are a professionally managed and growing organization which aims at strengthening and establishing itself as the foremost provider of healthcare services. We also aim at achieving greater and long-term growth. the Managing Director and Promoter Dr. Ashish Vishwas Rawandale is listed in Guinness World Records (twice), Ripley's believe it or not, Limca book of records, India book of records (multiple records), Asia book of records, World amazing records and World record academy for various achievements and innovations in urology. The objective of the Hospital namely Institute of Urology is to provide the people of Khandesh region of Maharashtra, the services of a super specialty hospital at an affordable rate. We are an integrated healthcare delivery service provider, committed to delivering quality healthcare services to the patients in modern facilities. the operations are divided across four key vertical streams in healthcare delivery, namely - "Pediatric Urology", "Adult Urology (Male, Female)", "Andrology and Sexual Dysfunction" and "Nephrology, Dialysis and Renal Transplant". The registered office of the Company was initially situated at 6th Floor, A Block, Shivsagar Estate, Dr. Annie Besant Road, Worli, Mumbai - 400 025. Pursuant to a Board resolution dated 13th March, 2015 the registered office was shifted to Unit No.11, Ground Floor, Town Centre, Andheri Kurla Road, Marol, Andheri (East), Mumbai-400 059, which is the current Registered Office.  MAJOR EVENTS AND MILESTONES: 2008 -Incorporation of the Company in the name and style of "Tejnaksh Healthcare Private Limited" -Set up Hospital in Dhule, Maharashtra 2014 -ISO Certification 2015 -Conversion in to a Public Limited Company 2016 -Tejnaksh Healthcare Ltd. has acquired Vedaant Multispecialty Hospital situated at Office No. 1 to 14, Natasha Tower CHS Ltd., Plot No. 84, Sector 17, Village Koparkhairane, Taluka and District Thane. 2017 -The Company has issued Bonus Shares in the Ratio of 1:1. 2018 -The Company has issued Bonus Shares in the Ratio of 36:10. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 5/-.

The Company incorporated in Mumbai as "Tejnaksh Healthcare Private Limited" as on 18th February, 2008 as a private limited company under provision of companies Act 1956. Company was converted in to a Public Limited Company and consequently the name was changed to "Tejnaksh Healthcare Limited" vide fresh certificate of incorporation dated 10th March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra.We run an Institute of Urology, an ISO certified the international level Urology hospital, located in the heart of Dhule city, Maharashtra, India. The 24000 Sq. Ft. campus has a four storey building which houses the complete Urology setup. It provides a comprehensive range of services from consultations and investigations to treatment for Urology.We are equipped with all latest equipment and provide the whole range of services, the patients from local area do not feel the need to go to metropolitan areas for urological problems. The Institute is recognized by National board of examinations for DNB (Urology). The Institute boasts of 150 research publications and 23 innovations.We are a professionally managed and growing organization which aims at strengthening and establishing itself as the foremost provider of healthcare services. We also aim at achieving greater and long-term growth. the Managing Director and Promoter Dr. Ashish Vishwas Rawandale is listed in Guinness World Records (twice), Ripley's believe it or not, Limca book of records, India book of records (multiple records), Asia book of records, World amazing records and World record academy for various achievements and innovations in urology. The objective of the Hospital namely Institute of Urology is to provide the people of Khandesh region of Maharashtra, the services of a super specialty hospital at an affordable rate. We are an integrated healthcare delivery service provider, committed to delivering quality healthcare services to the patients in modern facilities. the operations are divided across four key vertical streams in healthcare delivery, namely - "Pediatric Urology", "Adult Urology (Male, Female)", "Andrology and Sexual Dysfunction" and "Nephrology, Dialysis and Renal Transplant". The registered office of the Company was initially situated at 6th Floor, A Block, Shivsagar Estate, Dr. Annie Besant Road, Worli, Mumbai - 400 025. Pursuant to a Board resolution dated 13th March, 2015 the registered office was shifted to Unit No.11, Ground Floor, Town Centre, Andheri Kurla Road, Marol, Andheri (East), Mumbai-400 059, which is the current Registered Office.  MAJOR EVENTS AND MILESTONES: 2008 -Incorporation of the Company in the name and style of "Tejnaksh Healthcare Private Limited" -Set up Hospital in Dhule, Maharashtra 2014 -ISO Certification 2015 -Conversion in to a Public Limited Company 2016 -Tejnaksh Healthcare Ltd. has acquired Vedaant Multispecialty Hospital situated at Office No. 1 to 14, Natasha Tower CHS Ltd., Plot No. 84, Sector 17, Village Koparkhairane, Taluka and District Thane. 2017 -The Company has issued Bonus Shares in the Ratio of 1:1. 2018 -The Company has issued Bonus Shares in the Ratio of 36:10. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 5/-.

Read More

Parent Organisation

Tejnaksh Healthcare Ltd.

Founded

18/02/2008

Managing Director

NSE Symbol

FAQ

The current price of Tejnaksh Healthcare Ltd is

The 52-week high for Tejnaksh Healthcare Ltd is

The market capitalization of Tejnaksh Healthcare Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Tejnaksh Healthcare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Tejnaksh Healthcare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Tejnaksh Healthcare Ltd shares.

The CEO of Tejnaksh Healthcare Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT